Xiaosong He holds a doctorate in molecular biology. He has extensive experience in developing recombinant vaccines based on different vector systems and evaluating immune responses after vaccination. His recent research, which has focused on human T cell immunity against viral pathogens (in particular, hepatitis C virus), is important for the design of preventive and therapeutic vaccines for viruses that cause persistent infections. He also has considerable experience training, advising and supervising medical students and graduates on research projects and thesis work. As a researcher, he does not see patients.
Rheumatology, Allergy and Clinical Immunology
B.S., Fudan University, Shanghai, China, 1982
Stanford University School of Medicine, Palo Alto, California, 1993
Select Recent Publications
He X, Rehermann B, Lopez-Labrador FX, Boisvert J, Cheung R, Mumm J, Wedemeyer H, Berenguer M, Wright TL, Davis MM, Greenberg HB. Quantitative analysis of hepatitis C virus-specific CD8+ T cells in peripheral blood and liver using peptide-MHC tetramers. PR